September is National Sickle Cell Awareness Month. We honor and hope for all the #SickleCellWarriors who strive and survive and thrive every day.
Did you know the Partners Program hosts CME accredited sickle cell disease (SCD) modules, free to the public? The website, www.PartnersPRN.org, hosts three CME activities covering the issues facing adolescents and young adults (AYAs) with SCD and the phase of transitioning from a pediatric care model to an adult care model, a period associated with significantly increased risk for care discontinuity, acute complications, and death. Authored by Dr. Emily Riehm Meier, Pediatric Hematologist and Sickle Cell Research Director at the Indiana Hemophilia and Thrombosis Center in Indianapolis, these CME activities detail the most important and modifiable barriers to better outcomes among AYAs with SCD: underutilization of hydroxyurea, lack of comprehensive care for these patients, and need for structured transition programs to shepherd patients through the transition period. Would you like to gain more education about these important and timely topics - and earn free CMEs? https://partnersprn.org/online/index.php?category=0-25 These CME activities offer a patient-centered and practical approach to managing the care and transition of AYAs with SCD with a vision toward extending life expectancy, improving quality of life, and increasing competency among care providers for persons with SCD. Learn more by clicking the link. To complete an activity, you must be registered and logged in. https://partnersprn.org/online/index.php?category=0-25
0 Comments
Since 1983, the United States government has recognized September as Sickle Cell Awareness Month. In the thirty-four years since, a great deal of progress has been made with regards to research and treatment. In fact, activity in these two combined areas has led to a doubling of the average life expectancy for Sickle Cell patients in the United States. That is obviously great news that we can all appreciate and salute. We are making great strides at an accelerated rate and with the advent of the new CRISPR technology (https://www.yourgenome.org/facts/what-is-crispr-cas9), we stand on the verge of having a cure that, one day, can be accessible to more patients than stem cell transplants. But that day is still in the future.
The Sickle Cell community applauds these advances, but we need to remain focused on those individuals that face day after day of unrelenting pain, missed life opportunities and burdensome financial challenges. We must remain fixated on the needs of patients and families who face lives of uncertainty and recurrent flirtations with despair. And we should remain determined to do everything in our power to mitigate and/or minimize the many compounding issues that affect the members of our Sickle Cell community. We are not alone in this and we remain grateful that, now more than ever before, Sickle Cell advocacy and activism is at an all-time high. This brings us to an important point. For thirty-four years we have heard the words “Sickle Cell Awareness.” Awareness is only one part of the solution. Even so, it continues to amaze us that we still have so much awareness work to do. Too many people still don’t know much about Sickle Cell. A nursing student recently said, “I wish they would have spent more time on Sickle Cell. One class. That’s all we had.” This young woman was aware of Sickle Cell but she really didn’t know how to care for people who have it. This is just one example of why we need more than awareness to make a meaningful impact on this illness. We need to combine increased awareness with increased action. Whether it is institutionalizing a way that ensures that healthcare providers undergo more intensive training on Sickle Cell care or creating increased opportunities for Sickle Cell patients to access higher levels of education and employment, we need to take action that can make a difference. Awareness can’t do that by itself. It takes action to make things change. Gary Gibson; President/CEO Martin Center Sickle Cell Initiative |